Pomegranate Ellagitannin Extract, graded Moderate-evidence on Magellan — human trials and meta-analyses support small blood-pressure reductions (a few mmHg) and one year-long trial suggests memory preservation, but at least one systematic review calls the blood-pressure evidence weak. Magellan links 25 peer-reviewed citations for Pomegranate Ellagitannin Extract.
Source: Phytother Res 2021, PMID 34542202 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: high
Pomegranate ellagitannin extract is a concentrated source of ellagitannins (such as punicalagins) and ellagic acid, the polyphenols responsible for much of the pomegranate's antioxidant activity. After ingestion, these compounds are hydrolyzed to ellagic acid and then metabolized by the gut microbiota into urolithins, chiefly urolithin A. Urolithin A is a postbiotic that stimulates mitophagy, the cellular quality-control process that recycles damaged mitochondria, and the capacity to produce it varies substantially between individuals depending on gut microbiome composition.
In human research, the ellagitannin-derived metabolite urolithin A has improved muscle strength, endurance, and biomarkers of mitochondrial function and inflammation in randomized trials of middle-aged and older adults, and a small 2025 trial found more youthful immune-cell profiles after four weeks, although several primary endpoints (e.g., peak power, maximal ATP production) were not met. Separately, pomegranate juice and extracts have modestly lowered blood pressure (a few mmHg on average) in meta-analyses of randomized trials — though at least one systematic review rates that evidence as weak — and a year-long trial found daily juice helped preserve visual memory while placebo declined. The mitophagy findings come mainly from the purified metabolite rather than the extract itself, and urolithin production varies widely between individuals. This evidence describes the ellagitannins, urolithin A, and the pomegranate polyphenols themselves, not this specific commercial extract product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“urolithin A is safe and can improve mitochondrial biomarkers in elderly patients”
“LDL-cholesterol and oxidized LDL dose-dependently decreased, correlated with urolithin production”
“Ellagitannins and their gut-derived metabolites, the urolithins, modify gene expression in colon”
“Compared with the placebo group, POMx supplement significantly reduced the score of DAS28 (P<0.001) which could be related to the decrease in swollen (P<0.001) and tender joints (P=0.001) count, pain intensity (P=0.003) and ESR levels (P= 0.03).”
“Significant decreases in Western Ontario and McMaster Universities Osteoarthritis index (WOMAC) total score (P = 0.01), stiffness score (P = 0.00) and physical function score (P = 0.01) were observed in PJ group after the intervention.”
“This evidence-based review highlighted the potential of pomegranate extract being used for treating bone loss in osteoporosis, osteoarthritis and rheumatoid arthritis.”
Research describes the active mechanism and is not a claim about this specific product.
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
Across meta-analyses and randomized trials, creatine monohydrate combined with…
In humans, randomized trials and meta-analyses most consistently show that astaxanthin…
Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…
Yes — its active compound is linked to 25 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.